TNDM logo

TNDM
Tandem Diabetes Care Inc

13,983
Mkt Cap
$1.27B
Volume
1.03M
52W High
$29.65
52W Low
$9.98
PE Ratio
-6.06
TNDM Fundamentals
Price
$18.61
Prev Close
$18.81
Open
$18.25
50D MA
$21.64
Beta
1.28
Avg. Volume
1.96M
EPS (Annual)
-$3.04
P/B
8.19
Rev/Employee
$405,894.40
$1,635.63
Loading...
Loading...
News
all
press releases
JPMorgan Chase & Co. Sells 203,183 Shares of Tandem Diabetes Care, Inc. $TNDM
JPMorgan Chase & Co. lowered its position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 36.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 359,071 shares of the medical device company's stock after...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2026 results after the financial markets close on Thursday...
Business Wire·3d ago
News Placeholder
Tandem Diabetes Care (NASDAQ:TNDM) Trading Down 6.6% - Time to Sell?
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 6.6% - Time to Sell...
MarketBeat·9d ago
News Placeholder
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Analysts
Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Get Free Report) have been assigned a consensus rating of "Hold" from the nineteen analysts that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, nine have issued a hold recommenda...
MarketBeat·9d ago
News Placeholder
Assenagon Asset Management S.A. Invests $26.99 Million in Tandem Diabetes Care, Inc. $TNDM
Assenagon Asset Management S.A. purchased a new position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) during the fourth quarter, according to the company in its most recent filing with...
MarketBeat·10d ago
News Placeholder
Tandem Diabetes Care Maps Pharmacy Shift, Targets 65% Gross Margin and 2026 Mobi Tubeless Launch
Executives from Tandem Diabetes Care (NASDAQ:TNDM) outlined how a shift toward the pharmacy channel, an expanding product portfolio, and international buildout are expected to reshape the company's revenue mix and margin profile over the next several years during an investor discussion hosted by Opp...
MarketBeat·14d ago
News Placeholder
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Up 5.3% on Analyst Upgrade
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Up 5.3% Following Analyst Upgrade...
MarketBeat·17d ago
News Placeholder
This Union Pacific Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday
Top Wall Street analysts upgraded Carnival Corp, Tandem Diabetes Care, and Union Pacific Corp. Analysts see potential in UNP stock.read more...
Benzinga·17d ago
News Placeholder
Truist Financial Upgrades Tandem Diabetes Care (NASDAQ:TNDM) to "Buy"
Truist Financial raised shares of Tandem Diabetes Care from a "hold" rating to a "buy" rating and raised their price target for the company from $27.00 to $35.00 in a research report on Thursday...
MarketBeat·17d ago
News Placeholder
Strength Seen in Tandem Diabetes Care (TNDM): Can Its 9.1% Jump Turn into More Strength?
Tandem Diabetes Care (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·18d ago
<
1
2
...
>

Latest TNDM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.